Welcome …
… to this first edition of the RELIVE flash, a news-flash for principal investigators, data managers, clinical research associates and everyone else who actively works for the RELIVE project. You are also invited to visit our website https://relive-international.net where all the documents necessary for the activation of the project are available. The website and project was presented and well received at the recent SIOPEL virtual meeting in Munich.
|
|
The flash will appear about four times per year and is intended to keep you updated on all aspects of the RELIVE project. We would also love to hear from you, so please contact us for whatever topic and give us your news or concerns, we would be delighted to share it with everyone.
Marc Ansari
|
|
Status of activation
The study has been activated in Switzerland, and the first patient from Geneva University Hospital has been documented.
- Ethics Committee approval has been obtained in Italy, Spain and Poland
- In the Netherlands and in France, EC approval is not necessary.
- In Germany, Japan, the UK and Belgium, EC submission is ongoing.
- In the US and Canada, negotiations are under way to obtain the necessary approvals.
|
|
|
|
|
|